
Please try another search
Name | Title | Since | Until |
---|---|---|---|
Scott Wilkin | - | 2016 | Now |
Biography | Scott is the Head of the Global Intrinsic Value Equity team and co-PM for our Global equity portfolios. He is also Director of Research (DOR); responsible for managing the 13-member analyst team and driving research quality standards across the Global Intrinsic Value platform. In 2012, Scott was promoted to the position of DOR for the US Intrinsic Value equity team. In this role, Scott managed a team of six sector-based analysts and lead company and industry-level research. Scott was also the lead portfolio manager of the Intrinsic Value equity team's Global Healthcare and UBS Healthcare Long/Short strategies. Prior to being named DOR and portfolio manager, Scott was a Senior Investment Analyst and Sector Head for the health care analyst team. His responsibilities included fundamental company and industry-level research. | ||
Matthew Konosky | - | 2016 | Now |
Biography | Matthew Konosky is the Lead Healthcare Portfolio Manager and a Senior Investment Analyst on UBS Asset Management's US Intrinsic Value Equity Team. In his portfolio manager role, Matthew is Lead Portfolio Manager for the Global Healthcare Lux Fund as well as Deputy Portfolio Manager for the Global Biotech Lux Fund. Analyst responsibilities include fundamental company and industry-level research and development of company earnings models for the global pharmaceuticals and health care services sectors. Prior to joining the firm in 2006, Matthew worked as health care services analyst at Sanford C. Bernstein in New York and as a senior consultant at Mars & Co. serving several Fortune 500 health care clients. Matthew has also served as a member of the MIT Educational Counsel since 1997. | ||
Florian Töpfl | - | 2019 | 2023 |
Christian Suter | - | 2016 | 2019 |
Biography | Christian Suter is an Equity Specialist, based in Zurich. He works closely together with the equity investment teams of UBS Asset Management and is responsible for presenting equity strategies to clients, prospects and consultants, primarily focusing on our Swiss, Biotech and Healthcare strategies. Further Christian is the deputy portfolio manager for the Swiss High Dividend and Swiss Income strategies and acts as a member of the portfolio construction team for Swiss Equities. In addition Christian covers Swiss Small and Mid Cap Industrials as well as the Biotech sector as an analyst. In 2009, Christian joined UBS within the graduate training program for the second time, after he made his first experiences at UBS before University in UBS WM&SB and UBS Investment Bank. | ||
Ian McIntosh | Vice President | 2012 | 2016 |
Biography | Ian McIntosh is a Senior Portfolio Manager on the US Intrinsic Value Equity team. He is also Deputy Head of Active Equities. Prior to joining UBS Asset Management in 2004, Ian was a Vice President at JP Morgan Fleming Asset Management in New York. Ian led teams responsible for the global equity dividend discount model, a structured equity portfolio optimizer and fixed income front-office analytics. Ian began his career at the JP Morgan Investment Bank in London as a Quantitative Systems Analyst. He was responsible for developing exotic FX option analytics and a relative-value proprietary trading model. Ian is a Regular Member of the CFA Society of Chicago and the CFA Institute. | ||
Jan Scherer | - | 2010 | 2012 |
Management Team | - | 1998 | 2010 |
Biography | Team Managed |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review